Epigral rallied 3.06% to Rs 1,359.50 after the company’s net profit jumped 57.44% to Rs 77.27 crore on 11.26% increase in revenue from operations to Rs 524.63 crore in Q4 FY24 over Q3 FY24.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
